Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Morganella morgagnii
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
doi: 10.3389/fnagi.2019.00088 98 DeaconCFJohnsenAHHolstJJ
The primary risk with any compounded drug is the quality control of the pharmacy producing it
Established in 2011, Innovent is committed to discovering and developing, manufacturing and commercializing high-quality innovative medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, and ophthalmology diseases to enhance the quality of the patients' lives
No human clinical trials of 5-Amino-1MQ in obesity, sarcopenia, or any other indication have been published in peer-reviewed journals
US$ 22.26
US$ 22.98
US$ 28.61
US$ 27.57
US$ 25.30
US$ 21.77
US$ 29.47
US$ 24.15
US$ 27.67
US$ 20.33
US$ 22.78
